← Open Payments lookup

VIVENS ULYSSE: Open Payments

NPI 1487332615 · WALPOLE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,034 in 51 payments from 12 companies in 2025. Trend: 2023 $530 · 2024 $1,160 · 2025 $1,034

Food & beverage: $925Education: $109
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.17$213
Otsuka America Pharmaceutical, Inc.8$142
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$119
Teva Pharmaceuticals USA, Inc.4$117
Alkermes, Inc.4$94
Axsome Therapeutics, Inc.3$78
E.R. Squibb & Sons, L.L.C.3$73
Janssen Pharmaceuticals, Inc2$65
Lundbeck LLC2$48
Collegium Pharmaceutical, Inc.2$34

Products named: FANAPT, REXULTI, CAPLYTA, AUSTEDO XR, COBENFY, SPRAVATO, Auvelity, ARISTADA.

Industry payments across MA — which companies pay providers there.